Pancreatic Cancer Research

ResearcherXinjiang Medical UniversityNo recent work listed

Wei Ding

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6990-8621; OpenAlex author ID A5086036571. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Development and validation of a gene signature for pancreatic cancer: based on inflammatory response-related genes. First author DOI 10.1007/s11356-022-23252-w↗
  2. Efficacy and safety of Kanglaite injection combined with radiochemotherapy in the treatment of advanced pancreatic cancer: A PRISMA-compliant meta-analysis. Last author DOI 10.1097/md.0000000000016656↗
  3. Interaction of polymorphisms in xeroderma pigmentosum group C with cigarette smoking and pancreatic cancer risk. Co-author DOI 10.3892/ol.2018.9350↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongbiao Ma · 1 shared paper, 2023 · strength 0.24
  2. Manjiang Li · 1 shared paper, 2023 · strength 0.24
  3. Futian Du · 1 shared paper, 2023 · strength 0.24
  4. Jianling Liu · 1 shared paper, 2019 · strength 0.16
  5. Xin‐Jian Xu · 1 shared paper, 2018 · strength 0.10
  6. Xiyan Wang · 1 shared paper, 2018 · strength 0.10
  7. Dong Yan · 1 shared paper, 2018 · strength 0.10
  8. Xiao‐Hui Liang · 1 shared paper, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.